How to Choose the Best Weight Loss Medication for You

By Your Health Magazine Contributor

Your Health Magazine Contributor

. https://YourHealthMagazine.net

More Weight Control, Nutrition & Exercise Articles

How to Choose the Best Weight Loss Medication for You

Choosing a weight loss medication can feel confusing. Some treatments are weekly injections, others are daily tablets, and the headlines often focus on whichever medicine produces the biggest weight loss.

But a clinical trial result cannot tell you everything. A treatment also needs to suit your health, fit your routine and be manageable over time.

The best weight loss medication for you depends on your medical history, treatment goals, possible side effects and preferences. A qualified prescriber can help you weigh up these factors before deciding whether medication is appropriate.

Start by checking whether medication is suitable

Weight loss medicines are used alongside dietary changes and physical activity. They may be considered when someone’s weight is affecting their health and additional support is needed. Eligibility depends on the medicine, your body mass index (BMI) and any associated health conditions.

For several treatments, the adult licensing criteria include a BMI of 30 or above, or a BMI between 27 and 30 with at least one weight-related condition, such as type 2 diabetes or high blood pressure. These thresholds apply to the newly approved Wegovy and Foundayo tablets, for example. Other medicines have different criteria; the 7.2 mg Wegovy injection, for instance, is licensed for adults with obesity with a BMI of 30 or above.

NHS access also follows specific prescribing and funding criteria, which can be narrower than a medicine’s licence. Your GP or weight management service can explain the options available to you.

What are the main weight loss medication options?

Understanding how treatments differ can make your consultation more useful.

These options have different precautions and prescribing requirements. Orlistat works differently from appetite-regulating medicines, so tablets should not be treated as one interchangeable category.

How much weight could you lose?

Effectiveness matters, but compare research carefully. Studies can use different doses, follow participants for different lengths of time and include people with different health conditions.

A 72-week head-to-head trial in adults with obesity without type 2 diabetes found average weight reductions of 20.2% with tirzepatide and 13.7% with semaglutide. Participants received their maximum tolerated doses of tirzepatide 10 or 15 mg or semaglutide 1.7 or 2.4 mg weekly.

Those figures are averages, not personal predictions. They also do not compare tirzepatide with the newer 7.2 mg Wegovy dose, which has separate UK approval for eligible adults with obesity.

Ask your prescriber what a meaningful response would look like for you and when they would review progress. A useful goal might include improvements in mobility or an existing health condition, alongside weight reduction.

Would an injection or a tablet fit your routine?

Think about the practical demands of taking a medicine consistently.

A weekly injection may appeal if you would rather avoid a daily tablet. However, you need to feel comfortable using the pen and following its storage instructions.

Tablets avoid needles, but their instructions differ:

• Wegovy tablets require an empty stomach and a wait of at least 30 minutes before food, drink or other oral medicines.
• Foundayo can be taken once daily at any time, without food or water restrictions.
• Orlistat is taken around meals containing fat; the dose is omitted when a meal is missed or contains no fat.

Consider your morning routine, shift patterns, travel and other medicines. The most convenient option is the one whose instructions you can reliably follow.

Which treatment has the fewest side effects?

There is no single answer for everyone. Tolerability varies, and taking a tablet does not remove the possibility of digestive symptoms.

GLP-1-based treatments can cause nausea, vomiting, diarrhoea and constipation. Orlistat commonly causes oily stools, wind and an urgent need to use the toilet, particularly with higher-fat meals.

Discuss what to do if symptoms interfere with eating, drinking or daily activities. Follow your prescribed dose schedule and seek advice before increasing or changing treatment.

Severe, persistent abdominal pain, particularly pain spreading to the back, needs urgent medical assessment because it may indicate pancreatitis. Sudden loss or rapid deterioration of vision during semaglutide treatment also requires urgent assessment.

Could your medical history influence the choice?

Your prescriber needs a complete picture of your health and current medicines. Mention previous treatment problems, pregnancy plans and any conditions you are being monitored for.

Existing cardiovascular disease

Wegovy injection has a UK indication for reducing major cardiovascular events in adults with established cardiovascular disease and overweight or obesity. This may be relevant to treatment selection, but it does not mean every person taking Wegovy receives the same heart-health benefit.

Contraception and pregnancy plans

GLP-1 medicines should not be used during pregnancy, while trying to conceive or while breastfeeding. Discuss the required stopping interval before a planned pregnancy.

If you take the contraceptive pill and start Mounjaro, MHRA advice is to add a barrier method or switch to non-oral contraception for four weeks after starting and four weeks after each dose increase. Ask about contraception advice for your specific medicine.

Look beyond the starting price

If you are considering private treatment, request a clear breakdown of the ongoing cost.

Useful questions include:

• What will treatment cost at the intended maintenance dose?
• Are consultations, delivery and follow-up included?
• Who can help if side effects develop?
• What happens if treatment becomes unaffordable?

A starting offer alone cannot show whether a treatment will fit your longer-term budget.

Plan how progress will be reviewed

Before starting, agree on follow-up arrangements and how your response will be assessed. Reviews should consider tolerability, weight changes and whether continuing treatment remains appropriate.

Some medicines have specific review rules. For example, orlistat is generally not continued beyond three months if you have not lost at least 5% of your starting weight.

Dietary support and physical activity remain part of treatment. You should also have support to help maintain your weight if medication is stopped.

Frequently asked questions

Can you switch weight loss medicines?

Sometimes, but switching requires a prescriber’s plan. Do not assume that doses are equivalent or that you can overlap treatments. Discuss the change before stopping or starting a medicine.

Can you get weight loss medication online?

Prescription treatments can be supplied following an appropriate clinical assessment. Use a registered pharmacy and avoid unregulated sellers, which may supply falsified or unsafe products.

How should you prepare for a consultation?

Bring a list of your medicines, relevant medical history and previous weight management attempts. Explain what matters most to you, including convenience, cost and concerns about side effects. This gives your prescriber a practical starting point for a shared treatment decision.